Aim: To identify changes in the expression of genes coding for extracellular matrix (ECM) proteins in patients with noninflammatory corneal disorder keratoconus (KC), patients with corneal scarring, and normal controls.
INTRODUCTION
Cornea is a highly differentiated tissue, rich in extracellular matrix (ECM) synthesized by its cell constituents: Epithelial cells, stromal keratocytes, and endothelial cells. The corneal multilayered epithelium plays a protective role; highly organized collagen fibrils of a stroma ensure a transparency, and a single layer of endothelium regulates water transport and corneal homeostasis. The corneal matrix constitutes a major part of corneal stroma and is characterized by a well-defined supramolecular structure that ensures both corneal transparency and its protective role.
Keratoconus (KC) is a complex genetic noninflammatory corneal dystrophy characterized by progressive corneal thinning, resulting in moderate to marked visual impairment. 1 Recent genetic studies brought new insights into KC susceptibility genes, including identification of genes underlying both population variation in the central corneal thickness (CCT) and KC. 2 Several KC genes identified to date include genes coding for ECM components and regulators, such as gene coding for type V collagen subunit 1 (COL5A1) 3 collagen cross-linking enzyme lysyl oxidase, 4 ,5 ZNF469, 6, 7 and potentially other collagens. 8, 9 Varying abnormalities in the expression of different ECM components were identified in corneas of patients with KC by immunostaining, 10, 11 proteome profiling, 12, 13 comparative transcriptome profiling, 14, 15 analysis of expression levels of individual genes, 16 as well as in vitro studies of corneal stromal fibroblasts. 17 In this study, we analyzed the expression of genes for cell-cell and cell-matrix interactions in corneal tissue from KC patients, small group of patients with corneal scarring secondary to radial keratotomy surgery, and healthy controls. We employed the Human Extracellular Matrix & Adhesion Molecules RT² Profiler PCR Array (Qiagen, Valencia, CA) based on the real-time quantitative polymerase chain reaction (qPCR) method and optimized to target the most relevant genes.
MATERIALS AND METHODS

Subjects
Clinically affected KC patients were recruited from the Cornea Genetic Eye Institute. Institutional Review Board approval and written informed consent were obtained from all subjects. The study was conducted in accordance with the provisions of the Declaration of Helsinki.
Diagnosis
The diagnosis of KC was based on the clinical examination that included slit-lamp biomicroscopy, cycloplegic retinoscopy, and fundus evaluations, and confirmed with videokeratography. The slit lamp biomicroscope was used to identify stromal thinning, Vogts' striae, and/a Fleischer ring. The retinoscopy examination was performed with a fully dilated pupil (20 minutes after phenylephrine 2.5% and cyclopentolate 1% drops had been instilled in the eye) to determine the presence or absence of retroillumination signs of KC, such as the oil droplet sign and scissoring of the red reflex. Videokeratography evaluation was performed using the Topographic Modeling System (TOMEY, Nagoya, Japan). Subjects were assigned as having KC if they had at least one clinical sign and a confirmatory videokeratography map with an asymmetric bow-tie with skewed radial axis above and below the horizontal meridian pattern. 1 Keratoconus grade was assigned based on the average central keratometry readings as follows: Mild: K1 < 50D; moderate: K1 > 50D but < 55D; moderate-severe: K1 55-60D; severe: > 60D. Corneal scarring secondary to radial keratotomy surgery was diagnosed based on the slit lamp evaluation by the corneal clinician.
Tissue Collection and Processing
Corneal buttons from patients with KC and corneal scarring were obtained during penetrating keratoplasty. Tissue was kept on ice and was generally processed within 3 hours of surgical removal, but no later than within 24 hours. Corneal buttons were stored at -80°C in a freezer or in ribonucleic acid (RNA)-later reagent at -20°C in a freezer. Corneal buttons of normal controls were purchased from Minnesota Lions Eye Bank (St. Paul, MN, USA). They were shipped on ice and received within 24 hours of removal. 
Ribonucleic Acid Extraction and Quality Control
Analysis of differentially Expressed Genes
The threshold cycle (Ct) for each well was determined by real-time cycler software. Statistically significant differences in mean Ct values were determined using the RT 2 Profiler PCR Array Data Analysis software V.3.5 (SABiosciences ® ). The difference was considered significant when p < 0.05 and > 1.5 fold change. Genes with multiple undetermined Ct values in both KC and control samples were excluded from the final tables.
Reference Housekeeping Genes for Normalization
Reference genes bet a-2-m ic roglobu l i n (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyltransferase 1 (HPRT), and ribosomal protein, large, P0 (RPLP0) available on the PCR array were used for normalization of real-time PCR data. Beta actin (ACTB) was excluded from the list of reference genes due to its potential downregulation in the corneal stroma of patients with KC.
17-19
Genomic DNA Extraction homogenizer (Bertin) using three 45-second cycles of homogenization at 5,500 rpm with 2.8 mm ceramic beads.
Single Nucleotide Polymorphism Genotyping
COL5A1 single nucleotide polymorphisms (SNPs) rs7044529 and rs1536482 were genotyped using predesigned TaqMan ® genotyping assays (Applied Biosystems ® ) with allelic discrimination on ABI 7900 Real-Time PCR System (Applied Biosystems ® ) using the manufacturer's protocols.
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RESULTS
Patients
We compared 13 corneal buttons obtained from KC patients with 4 corneal buttons from unaffected individuals used as controls ( Table 1 ). The ages of KC patients varied from 18 to 59 (mean age = 34) years and controls from 42 to 66 (mean age = 56) years. All patients with KC had bilateral disease clinically; 12 out of 13 KC patients were Caucasians, and 1 patient was Asian. Keratoconus patients were assigned a KC grade from mild to severe based on the average central keratometry readings obtained during videokeratography. In addition, we analyzed two corneal buttons from patients with unilateral corneal scarring (mean age = 53.5) for which diagnosis of KC has been ruled out.
Unsupervised Clustering Analysis
Initial unsupervised clustering analysis of all 19 samples showed that gene expression profiles of KC corneas and corneas with scarring were clearly different from those of the control normal samples. Moreover, comparison of KC and scarring corneas revealed a number of differentially expressed genes (data not shown), suggesting that the development of KC and corneal scarring has different underlying mechanisms. However, due to the limited number of patients with corneal scarring, we could not perform accurate statistical testing of differences in gene expression, thus excluding scarring samples from further analysis. We also found a substantial difference in gene expression between Asian KC sample (see Materials Sample IDs correspond to the identification of specimens in Figure 1 and throughout the text Table 1 and throughout the text and Methods; Sample #4, Table 1 ) and 12 Caucasian KC samples. To eliminate ethnicity as a potential confounding factor, sample #4 was excluded from further analysis. As shown in Figure 1 , follow-up analysis of remaining 16 human corneal profiles that included 12 KC patients and 4 controls showed clear separation between KC RNA profiles and control RNA profiles and close clustering within each of these two groups (with the exception of control sample #5).
Identification of Genes differentially expressed in KC Corneas
We compared mean Ct values of 63 genes (Table 2) present on the array which passed through the quality control (see Methods) between KC corneas and control corneas using RT 2 Profiler PCR Array Data Analysis software and identified 21 differentially expressed genes; 16 genes were significantly downregulated in KC corneas (Table 3) , while 5 were upregulated (Table 4) . Among significantly downregulated genes, we identified a ubiquitous ECM glycoprotein fibronectin 1 (FN1), matrix metalloproteinase 9 (MMP9), two tissue inhibitors of metalloproteinases (TIMP1, TIMP2), three integrins (ITGA1, ITGA5, ITGAM), and four collagens (COL5A1, COL6A1, COL7A1, COL11A1). We have confirmed significant downregulation of thrombospondin 1 (THBS1) previously identified in the comparative transcriptome analysis of KC corneas.
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14 Interestingly, the expression levels of additional three collagen genes (Graph 1) were lower in KC patients when compared with controls. Notable novel genes we found downregulated in KC patients include disintegrin and metallopeptidase with thrombospondin type 1 motif gene (ADAMTS1) and secreted phosphoprotein 1 (SPP1). Among genes upregulated in KC patients, we identified transforming growth factor beta-induced (TGFBI or BIGH3) gene associated with multiple types of corneal dystrophy (see Discussion) and laminin beta 1 gene (LAMB1) mutated in a zebrafish model of ocular coloboma. 21 We also observed considerable upregulation of corneal epithelial keratinocyte-specific gene E-cadherin 1 (CDH1), integrin alpha 3 (ITGA3), and catenin (cadherinassociated protein) delta 1 (CTNND1).
Comparison of COL5A1 Gene Expression in KC Patients and Controls with Different COL5A1 SNP Genotypes
To test whether reduced expression of COL5A1 gene in KC patients is underlined by genetic variation, we have genotyped SNP rs1536482 located in the intergenic region between retinoid X receptor alpha and COL5A1 genes and rs7044529 located in the intron of COL5A1 gene, both previously associated with KC in the genetic studies 2,3 (Table 5 ). Due to the limited number of samples, we identified no homozygotes (KC or normal) for KC risk allele T of rs7044529, only two KC patients' homozygous for risk allele A of rs1536482. In addition, we were unable to perform statistical testing of differences in the COL5A1 expression in samples stratified based on genotypes for SNP rs7044529 since two controls were CT heterozygotes and two were homozygous for major allele C. Thus, we were only able to assess differences in COL5A1 expression in patients and controls heterozygous for risk allele at SNP rs1536482 and found that KC patients had lower COL5A1 expression compared with normal controls with the same genotypes; however, the difference did not reach statistical significance (fold change = 1.7, p-value = 0.06).
DISCUSSION
Using reliable real-time PCR-based method, we performed expression study of ECM molecules in patients with KC, controls, and small group of patients with corneal scarring. We identified threefold overabundance of downregulated genes, which is consistent with the destructive nature of the tissue degradation associated with KC and consistent with the transcriptome study of KC corneas.
14 Some of the genes differentially expressed in KC tissue are novel candidates, whereas some have been implicated before. In addition, some of them are specific to KC, while others have been described in other corneal pathologies. One of the notable newly identified downregulated genes is the SPP1 gene coding for SPP1 (also known as osteopontin) and an extracellular structural protein which participates in many physiological and pathological processes including wound and represents one of the most highly expressed proteins in corneal epithelial cells. 22 Another notable newly identified 
downregulated gene is the one coding for ADAMTS1. Disintegrin and metalloproteinase with thrombospondin motif proteins are involved in the proteolytic modification of cell-surface proteins and ECM components essential for various natural and pathological processes, including wound healing and cell differentiation. 23 Disintegrin and metalloproteinase with thrombospondin motif 1protein has been shown to be expressed by human corneal fibroblasts and to have a crucial role for normal growth and function of multiple tissues and organs, including supramolecular ECM structures of cornea and migration of corneal fibroblasts. 24 Gene variants of another member of the same gene family ADAMTS6 were found to be associated with CCT (but not with KC). 2 We also confirmed downregulation of THBS1 gene identified in high-throughput transcriptome analysis of KC corneas.
14 Genes coding for seven out of nine corneal collagens available on the array and reliably present in the tested tissue samples were downregulated in KC corneas, including four with statistically significant p values (Table 3 , Graph 1). This widespread downregulation could be used as a marker for KC. We observed decrease in the expression of COL5A1 gene in KC patients heterozygous for risk allele at SNP rs1536482 located in the COL5A1 genomic region when compared with normal controls with the same genotype ( Table 5, Table 6 ). Further analysis of variation in COL5A1 gene is needed to identify variants responsible for the reduced expression of collagen V in KC patients.
We also found significant downregulation of MMP9, TIMP1, and TIMP2 in KC corneas, confirming their involvement in KC strongly suggested by others. 25 However, conflicting results were identified in different studies of MMPs in KC tissue. 26 Tissue inhibitors of metalloproteinases regulate proteolytic activity of MMPs by binding to the MMP active site, and thus, low level of TIMP expression may provide alternative mechanism of increasing activity of MMP9 in corneal stroma without increasing its expression levels. Corneal structural integrity and repair processes largely depend on proper expression and function of integrins, important cell-surface molecules involved in cell-cell and cell-matrix interactions. 27 Several integrins are expressed on the surface of keratocytes and mediate keratocyte-ECM interaction essential for corneal matrix maturation and corneal structural integrity. 27 It has been reported that loss of integrin beta1 (which constitutes a part of important alpha5beta1 integrin) in keratocytes during stromal maturation results in corneal thinning. 28 Here, we show that the decrease in the other component of the same complex, integrin alpha 1 (ITGA1), is significantly associated with KC in the analysis of corneal expression. We observed upregulation of corneal epithelial keratinocyte-specific gene E-cadherin (CDH1). E-cadherin is involved in epithelial cell differentiation, 29 and its increased expression had been identified in multipotent stem cells located in the corneal stroma with possible ability to transdifferentiate into corneal epithelial cells, 30 indicating its importance in the mesenchymal-toepithelial transition-like processes. Another upregulated gene LAMB1 is elevated in corneas of lumican-deficient mouse corneas with stromal thinning. 31 And lastly, we found significantly increased expression of TGFBI (BIGH3) in KC patients when compared with controls. Transforming growth factor beta-induced protein (TGFBIP, also frequently called BIGH3) is an extracellular protein that mediates cell adhesion to collagen, laminin, FN, and proteoglycans, like decorin and biglycan with expression changes triggered by TGFB signaling pathway activation. 32 Transcript coding for TGFBI (BIGH3) was the second most abundant transcript identified in the cDNA library constructed from KC corneas by our group. 33 Transforming growth factor beta-induced gene mutations have been frequently identified in patients with corneal dystrophies, a group of heterogeneous conditions that are characterized by the progressive loss of corneal transparency 34 and lead to corneal abnormalities in transgenic mice. 35 Recently, potential mutation in TGFBI was identified in Chinese KC patients. 36 Transforming growth factor beta-induced protein has been identified in primary amyloid deposits of hereditary corneal dystrophies and in secondary amyloidosis of the cornea of diverse etiologies, 37 as well as in corneal stromal amyloid deposits in KC patients. 38 Increased levels of TGFBIP have been identified in corneas of patients with Fuchs' endothelial corneal dystrophy.
39,40
Interestingly, we found elevated levels of TGFBI expression in patients with corneal scarring, similar to those in KC patients, when compared with normal controls (data not shown). Our results add to the mounting evidence that TGFBI is universally upregulated among patients with different corneal abnormalities.
CONCLUSION
Abnormal expression of a number of genes coding for important ECM proteins including a number of collagens is associated with the development of KC in corneal tissue. 
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CLINICAL SIGNIFICANCE
Downregulation of corneal collagens and upregulation of TGFBI can be used as a potential screening and diagnostic tool for a variety of corneal abnormalities to assist corneal refractive surgeons with early diagnosis and prevention of laser-assisted in situ keratomileusisinduced complications.
